secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2022-01-20T23:59:59+00:00
Accession:  0001818093-22-000017
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health appoints Andrew Stanleick as President and CEO, effective Feb 7, 2022
--------------------------------------------------------------------------------

- Andrew Stanleick appointed President, CEO and board member effective Feb 7, 2022; Brent Saunders remains Executive Chairman.
- Base salary $800,000; target annual bonus 100% of base; $800,000 signing cash bonus subject to clawback within 12 months.
- Equity: 250,000 performance-based RSUs (stock price goals over 4 years); FY2022 annual grants of $4.5M time-based RSUs and $1.5M PSUs.
- Stanleick brings 25+ years beauty/retail experience, most recently EVP Americas at Coty and CEO of Kylie Jenner Beauty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/0001818093-22-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/skin-20220120.htm
  HTML page:      https://secwatch.observer/filing/0001818093-22-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer